Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bladder Cancer

  Free Subscription


10.02.2025

1 ACS Sens
1 Aktuelle Urol
1 Am Soc Clin Oncol Educ Book
1 Apoptosis
1 Asia Pac J Oncol Nurs
2 BMC Cancer
1 BMC Public Health
1 BMC Res Notes
1 Can Urol Assoc J
1 Cancer Immunol Immunother
1 Cancer Lett
1 Cancer Rep (Hoboken)
1 Clin Genitourin Cancer
1 Eur J Radiol
1 Eur Urol
1 Eur Urol Focus
1 Exp Mol Med
1 Front Immunol
1 Front Mol Biosci
1 Front Oncol
1 Hinyokika Kiyo
3 Int Braz J Urol
1 Int J Cancer
1 Int J Oncol
2 Int J Radiat Oncol Biol Phys
1 Int J Surg
1 Int J Urol
1 Iran J Basic Med Sci
1 iScience
1 J Cancer
1 J Cancer Res Clin Oncol
1 J Clin Oncol
2 J Registry Manag
1 J Urol
1 JNCI Cancer Spectr
1 Mol Imaging Radionucl Ther
2 N Engl J Med
1 Nat Commun
1 Pathobiology
2 Photodiagnosis Photodyn Ther
1 Rev Mal Respir
2 Sci Rep
3 Surg Pathol Clin
1 Theranostics
1 Urol Int
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Sens

  1. ZHOU H, Liu Q, Chen M, Xie Y, et al
    Urease-Driven Janus Nanomotors for Dynamic Enrichment and Multiplexed Detection of Bladder Cancer MicroRNAs in Urine.
    ACS Sens. 2025 Feb 5. doi: 10.1021/acssensors.4c02996.
    PubMed         Abstract available


    Aktuelle Urol

  2. GULER Y
    Clinical and pathological risk factors for tumour recurrence and upstaging in second TURBT for patients with NMIBC: a systematic review and meta-analysis.
    Aktuelle Urol. 2025;56:30-40.
    PubMed         Abstract available


    Am Soc Clin Oncol Educ Book

  3. ZARRABI KK, Saxena A, Mouw KW, Koshkin VS, et al
    Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma.
    Am Soc Clin Oncol Educ Book. 2025;45:e471924.
    PubMed         Abstract available


    Apoptosis

  4. CHEN Z, Zhang T, Li W, Hu J, et al
    Single-cell RNA sequencing analysis reveals the dynamic changes in the tumor microenvironment during NMIBC recurrence.
    Apoptosis. 2025;30.
    PubMed         Abstract available


    Asia Pac J Oncol Nurs

  5. XU M, Chen S, Liu X, Luo Y, et al
    Best evidence for rehabilitation management of urinary incontinence in patients with bladder cancer following orthotopic neobladder reconstruction.
    Asia Pac J Oncol Nurs. 2024;12:100647.
    PubMed         Abstract available


    BMC Cancer

  6. FURUKAWA J, Kakei Y, Murakami S, Kita H, et al
    Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial.
    BMC Cancer. 2025;25:195.
    PubMed         Abstract available

  7. LI P, Jing S, Kang Y, Feng B, et al
    Clinical outcomes of nephroureterectomy with bladder cuff excision or radical cystectomy for distal ureteral carcinoma invaded muscle of the ureteral orifice.
    BMC Cancer. 2025;25:221.
    PubMed         Abstract available


    BMC Public Health

  8. HUANG M, Li H, Chen J, Li L, et al
    Blood lead levels and bladder cancer among US participants: NHANES 1999-2018.
    BMC Public Health. 2025;25:416.
    PubMed         Abstract available


    BMC Res Notes

  9. KAWAHARA T, Kandori S, Kojima T, Mathis BJ, et al
    Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study.
    BMC Res Notes. 2025;18:47.
    PubMed         Abstract available


    Can Urol Assoc J

  10. KULKARNI GS, Black PC, Sridhar SS, Zlotta AR, et al
    2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer.
    Can Urol Assoc J. 2025;19:E1-E16.
    PubMed        


    Cancer Immunol Immunother

  11. YANAGISAWA T, Mori K, Matsukawa A, Kawada T, et al
    Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis.
    Cancer Immunol Immunother. 2025;74:76.
    PubMed         Abstract available


    Cancer Lett

  12. SCHOLTES MP, Akbarzadeh M, Galaras A, Nakauma-Gonzales JA, et al
    Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets.
    Cancer Lett. 2025 Jan 29:217506. doi: 10.1016/j.canlet.2025.217506.
    PubMed         Abstract available


    Cancer Rep (Hoboken)

  13. EBRAHIMI P, Mahdavian A, Mousavinejad M, Ghadimi DJ, et al
    An Unusual Presentation of Bladder Carcinoma in a Visceral Hernia: A Case Report and Literature Review.
    Cancer Rep (Hoboken). 2025;8:e70128.
    PubMed         Abstract available


    Clin Genitourin Cancer

  14. PAPPOT N, Maibom SL, Vejlgaard M, Joensen UN, et al
    Investigating the Potential to Offer Reproductive Organ Preserving Radical Cystectomy to More Female Bladder Cancer Patients.
    Clin Genitourin Cancer. 2025;23:102303.
    PubMed         Abstract available


    Eur J Radiol

  15. SRISAJJAKUL S, Prapaisilp P, Bangchokdee S
    VI steps to achieve VI-RADS assessment.
    Eur J Radiol. 2025;183:111868.
    PubMed         Abstract available


    Eur Urol

  16. HURLE R, Bernardini B, Contieri R, Lazzeri M, et al
    Re: Characterizing Psychological Resources and Resilience in Patients with Bladder Cancer: Associations with Frailty and Quality of Life.
    Eur Urol. 2025 Feb 3:S0302-2838(25)00022-3. doi: 10.1016/j.eururo.2025.
    PubMed        


    Eur Urol Focus

  17. MONTORSI F, Rosiello G, Moschini M, Salonia A, et al
    Re: Akihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al. Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort Studies. Eur Urol Focus. In press. https://do
    Eur Urol Focus. 2025 Feb 4:S2405-4569(25)00016-1. doi: 10.1016/j.euf.2024.
    PubMed        


    Exp Mol Med

  18. XU J, Koch J, Schmidt C, Nientiedt M, et al
    Loss of YTHDC1 m(6)A reading function promotes invasiveness in urothelial carcinoma of the bladder.
    Exp Mol Med. 2025;57:118-130.
    PubMed         Abstract available


    Front Immunol

  19. HUANG P, Wang J, Yu Z, Lu J, et al
    Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion.
    Front Immunol. 2025;16:1537808.
    PubMed         Abstract available


    Front Mol Biosci

  20. FRANCO LS, Arunachalam S, Chauhan A, Kareff SA, et al
    Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer.
    Front Mol Biosci. 2025;11:1520223.
    PubMed         Abstract available


    Front Oncol

  21. SUN J, Li Z, Zhu X
    Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis.
    Front Oncol. 2025;14:1486389.
    PubMed         Abstract available


    Hinyokika Kiyo

  22. YAMAMOTO S, Yamasaki T, Matsue T, Yukimatsu N, et al
    [The Case of Solitary Adrenal Metastasis of Urothelial Carcinoma].
    Hinyokika Kiyo. 2025;71:5-8.
    PubMed         Abstract available


    Int Braz J Urol

  23. SUARTZ CV, Martinez LM, Silvestre MHL, Lima RD, et al
    Urachal Carcinomas: A Comprehensive Systematic Review and Meta-analysis.
    Int Braz J Urol. 2025;51:e20240665.
    PubMed         Abstract available

  24. VILLOLDO GM, Gonzalez MI, Faune AV, Molina RC, et al
    Multicenter Retrospective Registry Study on BCG Use in Non-Muscle Invasive Bladder Cancer in Latin America: BLATAM (Bladder Cancer in Latin America) Group.
    Int Braz J Urol. 2025;51:e20240615.
    PubMed         Abstract available

  25. LOPES GMM, Gimenez LGS, Santana DS, Cardoso RB, et al
    Pelvic Lymph Node Dissection Before Versus After Radical Cystectomy: A Systematic Review and Meta-Analysis.
    Int Braz J Urol. 2025;51:e20240490.
    PubMed         Abstract available


    Int J Cancer

  26. YAMAMOTO A, Kawashima A, Uemura T, Nakano K, et al
    A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.
    Int J Cancer. 2025;156:1439-1456.
    PubMed         Abstract available


    Int J Oncol

  27. WAN X, Wang D, Zhang X, Xu M, et al
    Unleashing the power of urine?based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).
    Int J Oncol. 2025;66:18.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  28. LE REUN E, Espenel S, Garcia MA, Girbovan AH, et al
    Image-Guided Brachytherapy for Pediatric Bladder and/or Prostate Rhabdomyosarcoma: Toward an Increased Personalization of Treatment.
    Int J Radiat Oncol Biol Phys. 2025;121:658-666.
    PubMed         Abstract available

  29. MURTHY V, Maitre P, Bakshi G, Pal M, et al
    Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:728-736.
    PubMed         Abstract available


    Int J Surg

  30. XU C, Dong Y, Pei D, Zhang X, et al
    Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical study.
    Int J Surg. 2025 Feb 4. doi: 10.1097/JS9.0000000000002270.
    PubMed         Abstract available


    Int J Urol

  31. HARA S, Fukuokaya W, Miki J, Taoka R, et al
    Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.
    Int J Urol. 2025 Feb 5. doi: 10.1111/iju.70005.
    PubMed         Abstract available


    Iran J Basic Med Sci

  32. ZHENG Y, Wang K, Wu C, Qin Y, et al
    COTI-2 suppresses the malignancy of bladder cancer by inducing apoptosis via the AMPK-mTOR signaling pathway.
    Iran J Basic Med Sci. 2025;28:240-246.
    PubMed         Abstract available


    iScience

  33. PEIXOTO A, Ferreira D, Miranda A, Relvas-Santos M, et al
    Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells.
    iScience. 2025;28:111758.
    PubMed         Abstract available


    J Cancer

  34. XU HR, Pang Z, Wang QZ, Ou-Yang S, et al
    S100A8 promotes the proliferation, migration and invasion in bladder cancer cells.
    J Cancer. 2025;16:1066-1077.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  35. SCHNEIDEWIND L, Kiss B, Neumann T, Kranz J, et al
    Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC).
    J Cancer Res Clin Oncol. 2025;151:59.
    PubMed         Abstract available


    J Clin Oncol

  36. KAMAT AM, Frankel P
    Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
    J Clin Oncol. 2025 Feb 5:JCO2402482. doi: 10.1200/JCO-24-02482.
    PubMed        


    J Registry Manag

  37. MITCHELL S, Vida C
    Journal of Registry Management Continuing Education Quiz-FALL 2024: EVALUATION OF MELANOMA AND BLADDER CANCERS IN NEW HAMPSHIRE TO IDENTIFY REGISTRAR TRAINING NEEDS.
    J Registry Manag. 2024;51:128.
    PubMed         Abstract available

  38. LUNA V, Wirth B, Valenzuela PR, Zens MS, et al
    Evaluation of Melanoma and Bladder Cancers in New Hampshire to Identify Registrar Training Needs.
    J Registry Manag. 2024;51:121-123.
    PubMed         Abstract available


    J Urol

  39. HEER R, Boaz RJ, Tan WS, Gravestock P, et al
    Letter: Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.
    J Urol. 2025 Feb 7:101097JU0000000000004431. doi: 10.1097/JU.0000000000004431.
    PubMed        


    JNCI Cancer Spectr

  40. LARSSON SC, Chen J, Ruan X, Li X, et al
    Genome-wide association study and Mendelian randomization analyses reveal insights into bladder cancer etiology.
    JNCI Cancer Spectr. 2025 Feb 3:pkaf014. doi: 10.1093.
    PubMed         Abstract available


    Mol Imaging Radionucl Ther

  41. KAYA F, Komek H, Dursun IH, Senses V, et al
    Pseudoprogression Shown on (18)F-FDG PET/CT After Pembrolizumab Treatment in a Case of Metastatic Bladder Cancer.
    Mol Imaging Radionucl Ther. 2025;34:70-72.
    PubMed         Abstract available


    N Engl J Med

  42. POWLES T, Galsky MD, van der Heijden MS
    Perioperative Durvalumab in Bladder Cancer. Reply.
    N Engl J Med. 2025;392:619.
    PubMed        

  43. KOGA S, Mei L
    Perioperative Durvalumab in Bladder Cancer.
    N Engl J Med. 2025;392:618-619.
    PubMed        


    Nat Commun

  44. CONTRERAS-SANZ A, Negri GL, Reike MJ, Oo HZ, et al
    Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.
    Nat Commun. 2025;16:1240.
    PubMed         Abstract available


    Pathobiology

  45. JUNG M, Kim B, Lee JS, Kim JY, et al
    KRT18 as a Novel Biomarker of Urothelial Papilloma while Evaluating Low-Grade Papillary Urothelial Neoplasms: Bi-Center Analysis.
    Pathobiology. 2025;92:28-39.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  46. FUKUHARA H, Nishimura T, Shimojo Y, Inoue K, et al
    Comparison of fluorescence intensity of protoporphyrin IX as observed on the screen of different cystoscopic systems.
    Photodiagnosis Photodyn Ther. 2025;51:104425.
    PubMed         Abstract available

  47. SUZUKI S, Nagumo Y, Kojo K, Ikeda A, et al
    Variations in the diagnostic performance of transurethral resection of bladder tumor with photodynamic diagnosis according to surgical experience: A retrospective, single-center study.
    Photodiagnosis Photodyn Ther. 2025;51:104429.
    PubMed         Abstract available


    Rev Mal Respir

  48. ARGOULON N, Morel H, Lanotte P, Ferreira M, et al
    [Antibioprophylaxis failure with BCG therapy for bladder neoplasia].
    Rev Mal Respir. 2025;42:75-80.
    PubMed         Abstract available


    Sci Rep

  49. ALEM D, Garcia-Lavina CX, Garagorry F, Centurion D, et al
    Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.
    Sci Rep. 2025;15:4393.
    PubMed         Abstract available

  50. SISAKHT MM, Gholizadeh F, Hekmatirad S, Mahmoudi T, et al
    Cost-reduction strategy to culture patient derived bladder tumor organoids.
    Sci Rep. 2025;15:4223.
    PubMed         Abstract available


    Surg Pathol Clin

  51. BEAUCHAMP L, Indulkar S, Erak E, Salimian M, et al
    Tissue-Based Biomarkers Important for Prognostication and Management of Genitourinary Tumors, Including Surrogate Markers of Genomic Alterations.
    Surg Pathol Clin. 2025;18:175-189.
    PubMed         Abstract available

  52. PAPKE DJ JR
    Mesenchymal Neoplasms of the Bladder and Male Genital Tract, including the Perineum and Scrotum.
    Surg Pathol Clin. 2025;18:229-247.
    PubMed         Abstract available

  53. CHEN JF, Al-Ahmadie H
    Molecular Classification of Urothelial Carcinoma.
    Surg Pathol Clin. 2025;18:41-51.
    PubMed         Abstract available


    Theranostics

  54. LIU Z, Zhang C, Xiao J, He Y, et al
    TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance.
    Theranostics. 2025;15:1966-1986.
    PubMed         Abstract available


    Urol Int

  55. CHEN H, Wu M, Chen M
    Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma.
    Urol Int. 2025;109:8-17.
    PubMed         Abstract available


    Urology

  56. KUMAR S, Razaqi N, Mehta R, Sah R, et al
    Comment on "Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis".
    Urology. 2025 Jan 29:S0090-4295(25)00008-1. doi: 10.1016/j.urology.2025.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.